Latest News
Harbour BioMed IND for HBM7004 approved by China's NMPA
18 August 2026 - Global biopharmaceutical company Harbour BioMed (HKEX: 02142), which develops antibody therapeutics in immunology and oncology, said on Tuesday that China's National Medical Products Administration (NMPA) has approved its Invest...
Hansa Biopharma reports first Australian transplant using Idefirix
18 August 2026 - Swedish immunomodulatory therapy company Hansa Biopharma AB (STO: HNSA) on Tuesday announced that the first commercial patient in Australia has received a living donor kidney transplant following treatment with imlifidase (Idefirix),...
WuXi XDC's Singapore site BCM3 facility achieves GMP release
18 August 2026 - WuXi XDC Cayman Inc. (HKG: 2268), a China-based global Contract Research, Development and Manufacturing Organisation (CRDMO) involved in the bioconjugate industry, announced on Tuesday that its BCM3 dual-function production line for ...
Abbott and NACHC launch nationwide Food for Health initiative
18 August 2026 - American multinational medical devices and health care company Abbott (NYSE: ABT) and the National Association of Community Health Centers (NACHC) announced on Monday a multi-year 'food is medicine' effort, called the NACHC...
Lupin's Pitolisant Tablets receives US FDA approval
18 August 2026 - India-based global pharmaceutical company Lupin Limited (BSE: 500257; NSE: LUPIN; REUTERS: LUPIN.BO; BLOOMBERG: LPCIN) announced on Monday that it has received the final approval from the United States Food and Drug Administration (U...